SGI
CPRX

Summit Global Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Summit Global Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,573
Closed -$584K – 529
2026
Q1 		$584K Sell
23,573
-3,369
-13% -$80.3K 0.03% 307
2025
Q4 		$629K Sell
26,942
-33,375
-55% -$743K 0.04% 270
2025
Q3 		$1.19M Buy
60,317
+3,902
+7% +$80.2K 0.07% 163
2025
Q2 		$1.22M Sell
56,415
-13,586
-19% -$321K 0.07% 153
2025
Q1 		$1.7M Sell
70,001
-3,880
-5% -$87.4K 0.12% 101
2024
Q4 		$1.54M Sell
73,881
-3,411
-4% -$73.3K 0.1% 154
2024
Q3 		$1.54M Buy
77,292
+1,923
+3% +$35.6K 0.1% 162
2024
Q2 		$1.17M Sell
75,369
-11,333
-13% -$176K 0.08% 213
2024
Q1 		$1.38M Sell
86,702
-3,810
-4% -$57.4K 0.1% 151
2023
Q4 		$1.52M Sell
90,512
-6,883
-7% -$94.1K 0.1% 158
2023
Q3 		$1.14M Buy
97,395
+72,890
+297% +$975K 0.08% 194
2023
Q2 		$329K Buy
+24,505
New +$353K 0.02% 404
2021
Q4 		– Sell
-130,000
Closed -$689K – 554
2021
Q3 		$689K Buy
130,000
+72,500
+126% +$396K 0.05% 258
2021
Q2 		$331K Buy
+57,500
New +$297K 0.02% 441

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Summit Global Investments's CPRX Position: Q2 2026 in Review

Summit Global Investments sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 23,573 shares — an estimated $584K sold.

Summit Global Investments first reported a position in CPRX in Q2 2021 and held it in 14 quarters. The position peaked at $1.7M in Q1 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Summit Global Investments reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Summit Global Investments sold 23,573 Catalyst Pharmaceutical shares in Q2 2026, an estimated $584K.
  • Summit Global Investments first reported a position in Catalyst Pharmaceutical in Q2 2021 and held it in 14 quarters.
  • Summit Global Investments's Catalyst Pharmaceutical position peaked at $1.7M in Q1 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.